Adalimumab Aacf + Abatacept Interaction
Majorinteraction on record
Description
Increased risk of serious infection when combined with ADALIMUMAB-AACF. Concomitant use is not recommended in patients with RA.
Mechanism
TNF blocker combined with biologic DMARD increases infection risk
Source: NLP:adalimumab-aacf